December 2024 FDA Recall Drug by Shoppers- Plaza
D-0207-2025 - Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide

This Class I drug recall was voluntarily initiated by Shoppers- Plaza on December 16, 2024 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda; fda laboratory analysis confirmed product tainted with undeclared metformin and glyburide. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0207-2025

Reason for Recall
Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide
Initiated
12-16-2024
Reported
01-29-2025
Quantity
172 180-count bottles

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Nationwide via internet sales
FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7

Batch or Lot Expiration Information

Batch# 001, exp. date 09/10/2026